Central Retinal Vein Occlusion
📧 Sign up to get email alerts when something new happens for Central Retinal Vein Occlusion.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-11-28Clinical Trial Update: Prevention of Retinal Non-perfusion in Central Retinal Vein Occlusion by Hydroxycarbamide Treatment. [Phase 2]
An update on a Phase 2 trial evaluating hydroxycarbamide to prevent retinal non-perfusion in non-ischemic central retinal vein occlusion. Th…
-
CLINICAL_TRIALS trial_result · 2016-11-25Clinical Trial Update: Vitamin D Levels in Patients With Central Retinal Vein Occlusion- a Prospective Controlled Study
A completed prospective controlled study evaluating vitamin D levels in patients with central retinal vein occlusion.
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion [Phase 3]
A Phase 3 clinical trial evaluating intravitreal ranibizumab for visual impairment due to macular edema from central retinal vein occlusion …
-
CLINICAL_TRIALS trial_result · 2016-01-01Clinical Trial Update: Intravitreal Ranibizumab Treatment of Central Retinal Vein Occlusion With Macular Edema [Phase 1]
Phase 1 trial update evaluating intravitreal ranibizumab for central retinal vein occlusion with macular edema has completed.
-
CLINICAL_TRIALS research · 2015-12-14Clinical Trial Update: Ozurdex Versus Ranibizumab Versus Combination for Central Retinal Vein Occlusion [Phase 4]
A Phase 4 clinical trial comparing Ozurdex (dexamethasone intravitreal implant), ranibizumab, and their combination for macular edema due to…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-05-22Clinical Trial Update: Impact of Intravitreal Aflibercept Injections on Capillary Non-Perfusion [Phase 1, Phase 2]
A clinical trial update describing Phase 1/2 results on intravitreal aflibercept injections and their effect on capillary non-perfusion in c…
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab [Phase 1, Phase 2]
A Phase 1/2 trial evaluating intravitreal ranibizumab (0.5 mg or 1.0 mg) for macular edema due to branch or central retinal vein occlusion i…
-
CLINICAL_TRIALS research · 2015-04-01Clinical Trial Update: Hyperbaric Chamber for Central Retinal Vein Occlusion (CRVO) Patients [Phase 2]
A Phase 2 clinical trial update investigating hyperbaric chamber therapy for Central Retinal Vein Occlusion.
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO) [Phase 3]
Phase 3 trial evaluating the efficacy and safety of intravitreal ranibizumab versus dexamethasone implant for central retinal vein occlusion…
-
CLINICAL_TRIALS trial_result · 2015-02-10Clinical Trial Update: Post Market Surveillance of OZURDEX® for Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO)
Post-market surveillance results for OZURDEX (dexamethasone intravitreal implant) in branch retinal vein occlusion and central retinal vein …
-
CLINICAL_TRIALS trial_result · 2014-10-29Clinical Trial Update: Study of Intravitreal Aflibercept Injection for Persistent CRVO-associated Macular Edema Despite Prior Anti-VEGF Therapy [Phase 4]
Update on a Phase 4 trial evaluating intravitreal aflibercept (Eylea) for persistent macular edema due to central retinal vein occlusion in …
-
CLINICAL_TRIALS trial_result · 2014-08-13Clinical Trial Update: Hemodilution Versus Ranibizumab in Early-onset Central Retinal Vein Occlusion [Phase 4]
This ClinicalTrials.gov update notes the completion of a Phase 4 trial comparing hemodilution with ranibizumab for early-onset Central Retin…
-
CLINICAL_TRIALS trial_result · 2014-06-30Clinical Trial Update: A Study of a Sustained Release Fluocinolone Implant for Treatment of Central Retinal Vein Occlusion [NA]
This update summarizes results from a trial investigating a sustained-release fluocinolone implant for central retinal vein occlusion.
-
CLINICAL_TRIALS trial_result · 2014-06-25Clinical Trial Update: Ziv-aflibercept in Eyes With Retinal Diseases and Poor Vision-phase I [Phase 1]
Phase I clinical trial of Ziv-aflibercept for retinal diseases, including age-related macular degeneration and central retinal vein occlusio…
-
CLINICAL_TRIALS research · 2014-06-23Clinical Trial Update: Development of Intravitreal Ranibizumab by Determining the Pathogenesis of Macular Edema With Retinal Vein Occlusion [NA]
Clinical trial update describing the development of intravitreal ranibizumab to study the pathogenesis of macular edema associated with reti…
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Anesthesia Preference for Intravitreal Injection: Topical or Subconjunctival [NA]
A completed trial compared topical versus subconjunctival anesthesia for intravitreal injections in AMD, CRVO, and DME. Results were posted …
-
CLINICAL_TRIALS trial_result · 2014-03-19Clinical Trial Update: Predictive Factors of Ranibizumab Treatment in Macular Edema With CRVO [NA]
This clinical trial update describes factors that may predict how patients with macular edema due to Central Retinal Vein Occlusion respond …
-
CLINICAL_TRIALS trial_result · 2013-12-12Clinical Trial Update: Lucentis for Central Retinal Vein Occlusion (CRVO) [Phase 1]
This document reports the completion of a Phase 1 trial evaluating Lucentis (ranibizumab) for central retinal vein occlusion.
-
CLINICAL_TRIALS trial_result · 2013-12-12Clinical Trial Update: Lucentis for Macular Edema Associated With Central Retinal Vein Occlusion [Phase 1]
A Phase 1 trial evaluating Lucentis (ranibizumab) for macular edema due to Central Retinal Vein Occlusion has completed its Phase 1 study.
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO) [Phase 3]
This entry reports the completion of a Phase 3 trial evaluating VEGF Trap-Eye (aflibercept) for macular edema due to central retinal vein oc…
-
CLINICAL_TRIALS research · 2013-01-17Clinical Trial Update: Retinal Oxygen Saturation, Blood Flow, Vascular Function and High Resolution Morphometric Imaging in the Living Human Eye
A University of Toronto clinical trial is investigating retinal oxygen saturation, blood flow, vascular function, and high-resolution morpho…
-
CLINICAL_TRIALS trial_result · 2012-11-22Clinical Trial Update: Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO) [Phase 3]
A Phase 3 trial sponsored by Bayer evaluated VEGF Trap-Eye (aflibercept) for central retinal vein occlusion; results have been posted after …
-
CLINICAL_TRIALS trial_result · 2012-09-12Clinical Trial Update: Retinal Ischemia in Central Retinal Vein Occlusion, and the Effects of Treatment With Intravitreal Ranibizumab
The trial studied retinal ischemia in central retinal vein occlusion and the effects of intravitreal ranibizumab treatment.
-
CLINICAL_TRIALS trial_result · 2012-09-03Clinical Trial Update: The Effectiveness of Intravitreal Avastin Injection for CRVO
This clinical trial update assesses the effectiveness of intravitreal bevacizumab (Avastin) injections for central retinal vein occlusion. T…
-
FDA approval · 2012-02-24FDA Approved: OZURDEX — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for OZURDEX (dexamethasone) from Allergan, Inc.